CURRICULUM VITAE
Vladan P. Čokić
BORN:
March 17. 1971, Belgrade, Serbia
MARITAL STATUS: Married to Bojana B. Beleslin - Čokić
CHILDREN:
Milica (1995)
Jelisaveta (2001)
Natalija (2008)
WORK ADDRESS:
Laboratory of Experimental Hematology
Institute for Medical Research
Dr. Subotića 4, PO Box 102
11129 Belgrade, Serbia
Tel.: 381-11-2684-484, ext. 105
Fax: 381-11-2643-691
e-mail: vl@imi.bg.ac.rs
Web address: www.imi.bg.ac.rs
EDUCATION:
June 30.1990 September 27. 1996.
Degree:
Belgrade University
School of Medicine
Average grade:
8.53 (eight fifty three, out of ten)
MD
POSTGRADUATE
Belgrade University
SCHOOL FOR
School of Medicine, Division of Medical Genetics
MASTER DEGREE:
October 1.1996June 16. 2005
Degree:
Mr sci med
POSTGRADUATE
SCHOOL FOR
PhD DEGREE:
June 08.2006.–
Decembar 30.2009.
Degree:
Belgrade University
School of Medicine, Division of Hematology
Gene expression profile of hematopoietic progenitor cells in
chronic myeloproliferative disorders
Dr sci med
INTERNAL MEDICINE Belgrade University, School of Medicine,
RESIDENCY:
Clinical Center of Serbia, Belgrade, Serbia
April 01.2006.–
POSITION HELD:
October 1. 1996.September 30 1997.
Internship; School of Medicine, Belgrade, Serbia
November, 1997April, 1998
Postdoctoral training
Institute of Molecular Genetics and Genetic Engineering,
Belgrade, Serbia
April 20, 1998 April 10, 1999
Junior Research Associate,
Institute for Medical Research, Belgrade, Serbia
April 12, 1999April 12, 2004
Visiting Fellow, National Institutes of Health (NIH),
National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK), Laboratory of Chemical Biology (LCB), Bethesda,
Maryland, USA
May 1, 2004 Junior Research Associate,
September 25, 2005
Institute of Medical Research, Laboratory of Experimental
Hematology, Belgrade, Serbia
September 26, 2005 - Research Associate,
Institute of Medical Research, Laboratory of Experimental
Hematology, Belgrade, Serbia
September 03, 2008 – Guest Researcher,
October 09, 2008
Division of Cellular and Gene Therapies, Center for Biologics
Evaluation and Research, US Food and Drug Administration,
Bethesda, MD, USA
May 19, 2010 Associate Professor of Research,
Institute of Medical Research, Laboratory of Experimental
Hematology, Belgrade, Serbia
COURSES OR
MEETINGS:
1. ICGEB Theoretical / Practical Course nucleic Acids base methods
in human and veterinary medicine Skopje, FYROM; May 25-29,1998
2. Recombinant DNA Methodology FAES, NIH, Bethesda, MD;
Summer Session, 1999
3. American Society of Hematology Forty-First Annual Meeting,
New Orleans, LA; December 3-7, 1999
4. Computer Training Program:
1) Introduction to the Helix Program
2) Getting Started with GCG
3) Genetics Computer Group (GCG) Sequence Analysis
4) Advanced Sequence Analysis Using the Wisconsin Package
(GCG)
Center for Information Technology (NIH); Fall Term 1999
5. Molecular Regulatory Networks in Cell Biology FAES, NIH,
Bethesda, MD; Spring Semester 2000
6. American Society of Hematology; Forty-Second Annual Meeting
San Francisco, CA; December 1-5, 2000
7. Transactivation of fetal hemoglobin genes for treatment of sickle
cell disease and Cooley’s anemia (RFA Grantees’ meeting);
Rockledge II Building, Bethesda, MD; October 21, 2001
8. Eryhtroid Cell Lineage Genomic Anatomy Project Workshop
(NIDDK); Sheraton Columbia Hotel Columbia, MD; December
19-20, 2001
9. 30th Anniversary Combined Meeting of the National Sickle Cell
Disease Program and the Sickle Cell Disease Association of
America; Washington Hilton & Towers Hotel, Washington, DC;
September 17-21, 2002
10. American Society of Hematology; 44th Annual Meeting,
Pennsylvania Convention Center, Philadelphia, PA; December 610, 2002
11. NIDDK GrantWriting Workshops, Bunim Room, NIH, Bethesda,
MD; March 2003
12. NIDDK New Investigators Workshop, Lister Hill Auditorium,
NIH, Bethesda, MD; April 7-8, 2003
13. Expression, Detection and Purification of Recombinant Proteins
in Procaryotic and Eucaryotic Cells; Foundation for Advanced
Education in the Science (FAES); NIH, Bethesda, MD, Spring
Session (April 23-25), 2003
14. The American Society of Hematology 45th annual meeting, San
Diego, CA; December 6-10, 2003
15. 5th Congress of the Balkan Union of Oncology. 14-17th October
2004, Belgrade, Serbia.
16. XII Hematological days SCG, Niš, Niška Banja, 27.10.30.10.2004.
17. Publishing in biomedicine: research studies and presentation of
results. Medical school, Novi Sad, 1-2.04.2005.
18. Immunotherapy of tumors (In memoriam akademik Ivan Spužić),
Serbian Academy of Sciences and Arts, Belgrade, 11.05.2005
19. 34th Annual Scientific Meeting of the International Society for
Experimental Hematology. University of Glasgow, Glasgow,
Scotland, UK. July 30 - August 2 2005.
20. International symposium on Genomics, Proteomics in
experimental and clinical oncology. Serbian Academy of Sciences
and Arts, Novi Sad, 30.09.2005
21. The first congress of physiological sciences of Serbia and
Montenegro with international participation: Molecular, cellular
and integrative basis of health, disease and therapy. Military
Medical Academy, Belgrade, November, 9–12, 2005.
22. The American Society of Hematology 47th Annual, Meeting and
Exposition. Georgia World Congress Center, Atlanta, Georgia,
USA. December 10-13, 2005
23. 15th Conference on Hemoglobin Switching, September 14-18,
2006. St. John’s College, Oxford, United Kingdom.
24. 36th Annual Scientific Meeting of the International Society for
Experimental Hematology (September 2007), Hamburg, Germany.
25. Fifth International Conference. Biology, Chemistry and
Therapeutic Applications of Nitric Oxide. Festspielhaus, Bregenz,
Austria. August 24-28, 2008.
26. Workshop on erythropoietin receptor (Epo-R) expression and
function in non-hematopietic tissues. The DoubleTree Bethesda
Hotel and Executive Meeting center, Bethesda, MD. September 89, 2008.
27. Statistical Analysis of Microarray Data. National Institutes of
Health, Bethesda, Building 12A, Room B51. October 7-8, 2008.
28. 8th Balkan Meeting on Human Genetics. Hotel Croatia, Cavtat,
Croatia, May 14-17, 2009.
29. 14th Congress of the European Hematology Association.
Internationals Congress Centrum (ICC), Berlin, Germany. June 47, 2009.
30. 15th Congress of the European Hematology Association. Fira de
Barcelona, Spain. June 10-13, 2010.
AWARDS:
1. Travel Award for the American Society of Hematology 47th Annual Meeting and
Exposition. Georgia World Congress Center, Atlanta, Georgia, USA. December
10-13, 2005.
2. Travel grant and complimentary registration for the 14th Congress of the European
Hematology Association. Internationals Congress Centrum (ICC), Berlin,
Germany. June 4-7, 2009
RESEARCH INTERESTS:
Molecular biology and genetics, Experimental and Clinical Hematology.
MEMBERSHIP IN INTERNATIONAL SOCIETIS:
International society of Experimental Hematology (ISEH);
European Hematology Association (EHA);
LIST OF PUBLICATIONS:
1. Beleslin-Cokic BB, Cokic V, Cemerikic D, Beleslin BB. Similarities and
differences in modulation of the outward potassium current by some monovalent
and divalent cations in leech Retzius nerve cells. Iugoslav Physiol Pharmacol Acta.
1996;32:369-73.
2. Beleslin BB, Dekleva M, Jovanovic Z, Beleslin-Cokic B, Cokic V. Resistivity of
different tissues to oxidative stress. Iugoslav Physiol Pharmacol Acta. 1998;34:3945.
3. Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT,
Schechter AN. Hydroxyurea induces fetal hemoglobin by the nitric oxide-
dependent activation of soluble guanylyl cyclase. The Journal of Clinical
Investigation. 2003;111(2):231-39.
4. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT.
Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide
production by endothelial cells. Blood. 2004;104(7):2073-80.
5. Bugarski D, Petakov M, Vlaski M, Krstic A, Cokic V, Jovcic G, Stojanovic N,
Milenkovic P. Signaling pathways implicated in hematopoietic progenitor cell
proliferation. Bulletin of hematology. 2004;32:156-159.
6. Cokic VP, Beleslin-Cokic BB, Tomic M, Stojilkovic, SS, Noguchi CT, Schechter
AN. Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells.
Blood. 2006;108:184-191.
7. Cokic VP, Beleslin-Cokic BB, Noguchi CT, Schechter AN. Hydroxyurea increases
eNOS protein levels through inhibition of proteasome activity. Nitric Oxide. 2007
May;16(3):371-8.
8. Cokic VP, Andric SA, Stojilkovic SS, Noguchi CT, Schechter AN. Hydroxyurea
nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood
2008;111:1117-1123.
9. Čokić VP, Schechter AN. The Effects of Nitric Oxide on Red Cell Development
and Phenotype. In: James Bieker, ed. Red Cell Development, Current Topics in
Developmental Biology. Vol 82. Burlington, MA: Academic Press; 2008: 169-215.
10. Čokić VP, Beleslin-Čokić BB, Smith RD, Economou AP, Wahl LM, Noguchi CT,
Schechter AN. Stimulated stromal cells induce gamma-globin gene expression in
erythroid cells via nitric oxide production. Exp Hematol. 2009 Oct;37(10):1230-7.
Epub 2009 Jul 2.
11. Čokić VP, Mojsilović S, Beleslin-Čokić BB, Gotić M, Milenković P. Gene
expression profiling of stem cells in chronic myeloproliferative disorders. In: Pavle
Milenković et al, ed. Current trends in tumor marker diagnosis: experience of FP6
HISERBS project. Institute for Medical Research, Belgrade: 2009: 160-184.
12. Antic D, Perunicic Jovanovic M, Dencic Fekete M, Čokić VP. Assessment of bone
marrow microvessel density in chronic lymphocytic leukemia. Appl
Immunohistochem Mol Morphol. 2010 February 23. [Epub ahead of print] DOI:
10.1097/PAI.0b013e3181d18ae2
POSTER PRESENTATIONS:
1. Dekleva M, Beleslin-Cokic B, Cokic V and Beleslin B. Similarity in the neurotoxic
action of some antiarrythmic agents and 4-aminopyridine. EEG and Clin.
Neurophysiol. (1996); 99, 336.
2. Beleslin-Cokic B, Cokic V, Cemerikic D and Beleslin B. Differences in modulation of
outward potassium channels by foreign cations in leech Retzius nerve cells. Acta Biol.
Med. Experim. (1996); 21, (Suppl. 1), 23.
3. Cokic VP, Beleslin-Cokic BB, Beleslin BB. Neuro-toxic action of Ba2 on leech
Retzius nerve cell. Third Xenobiotic Metabolism and Toxicity Workshop of Balkan
Countries. (1997), Varna, Bulgaria.
4. Beleslin-Cokic BB, Cokic VP, Beleslin BB. The effect of Ba2+ on ionic currents in
leech neurone. Yugoslav Congress in Clinical Neurophysiology. (1997) Herceg Novi,
Pp 31.
5. Beleslin-Cokic BB, Cokic V, Cemerikic D, Beleslin BB. Modulation of outward
potassium channels by foreign cations in leech Retzius neurons. J.Neurochem. (1998);
71, ( Suppl 1), S16C.
6. Beleslin-Cokic BB, Dekleva MN, Cokic V, Cemerikic D, Beleslin BB. Izostanak
proaritmogenog dejstva vodonik peroksida u odsustvu povecane aktivnosti ukupne
serumske kreatin kinaze. Kardiologija (1998); 19, (Suppl.1) 449.
7. Cokic VP, Ikonomi P, Beleslin-Cokic BB, Smith RD, Schechter AN. Measurement of
Nitric Oxide Synthase gene expression and nitric oxide production during erythroid
differentiation. Blood 96 (11):4322 Part 2 Nov 16 2000. American Society of
Hematology 42nd annual meeting (2000), San Francisco,CA;
8. Beleslin-Cokic BB, Yu X, Cokic VP, Weksler BB, Noguchi CT. Oxygen-dependent
proliferative response of human bone marrow endothelial cells to erythropoietin.
Blood 96 (11):155 Part 1 Nov 16 2000. American Society of Hematology 42nd annual
meeting (2000), San Francisco, CA;
9. Cokic VP, Smith RD, Beleslin-Cokic BB, Gladwin MT, Schechter AN. Nitric oxide
donors increase gamma-globin mRNA and HbF levels in cultured human erythroid
cells. Blood 98 (11):2065 Part 1 Nov 16 2001. American Society of Hematology 43rd
annual meeting (2001), Orlando, FL;
10. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi, CT.
Erythropoietin induction of NO Synthase and NO levels in Bone Marrow Endothelial
Cells. Blood 98 (11):1040 Part 1 Nov 16 2001. American Society of Hematology 43rd
annual meeting (2001), Orlando, FL;
11. Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT,
Schechter AN. Nitric oxide donors increase gamma-globin mRNA and HbF levels in
human erythroid cells similarly to hydroxyurea. Second international conference on
the biology, chemistry, and therapeutical applications of nitric oxide (2002), Prague,
Czech Republic.
12. Cokic VP, Beleslin-Cokic BB, Noguchi CT, Schechter AN. Stimulation of nitric oxide
production by hydroxyurea in transformed human bone marrow endothelial cells.
Second international conference on the biology, chemistry, and therapeutical
applications of nitric oxide (2002), Prague, Czech Republic.
13. Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT,
Schechter AN. Nitric oxide donors increase gamma-globin mRNA and HbF levels in
human erythroid cells similarly to hydroxyurea. Twelfth International Hemoglobin
Switching / Hematopoiesis Meeting (2002), Oxford University.
14. Cokic VP, Beleslin-Cokic BB, Slade MA, Noguchi CT, Schechter AN. Stimulation of
Nitric Oxide production by Hydroxyurea in Endothelial Cells and Macrophages.
Blood 100 (11):4227 Part 2 Nov 16 2002. American Society of Hematology 44th
annual meeting (2002), Philadelphia, PA;
15. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT.
Erythropoietin Stimulates a Nitric Oxide Response in Vascular Endothelial Cells.
Blood 100 (11):3760 Part 2 Nov 16 2002. American Society of Hematology 44th
annual meeting (2002), Philadelphia, PA;
16. Beleslin-Cokic BB, Cokic VP, Yu X, Schechter AN, Noguchi CT. Erythropoietin
Induces NO-synthase and NO-production in Human Endothelial Cells. 6th
International Lubeck Conference on the Pathophysiology and Pharmacology of
Erythropoietin and other Hematopoietic Growth Factors June 26-29, 2003. University
of Luebeck, Germany.
17. Cokic VP, Smith RD, Beleslin-Cokic BB, Gladwin MT, Schechter AN. Nitric oxide
donors induce fetal hemoglobin in human erythroid cells by a mechanism involving
cGMP. Blood cells molecules and diseases 31 (1):164-164 Jul-Aug 2003
18. Cokic VP, Beleslin-Cokic BB, Gladwin MT, Noguchi CT, Schechter AN.
Hydroxyurea-induced nitric oxide production: effects on human erythroid and
endothelial cells. International Society of Experimental Hematology (ISEH, 2003),
Paris, France.
19. Cokic VP, Beleslin-Cokic BB, Noguchi CT, Schechter AN. Hydroxyurea induction of
the eNOS - cGMP pathway in endothelial cells. Blood 102 (11):842A-842A 3130 Part
1 Nov 16 2003. American Society of Hematology 45th annual meeting (2003), San
Diego, CA;
20. Beleslin-Cokic BB, Gojkovic-Bukarica Lj, Cokic VP, Noguchi CT. Erythropoietin
stimulation of isolated human blood vessels and vascular smooth muscle cells. Blood
102 (11):533A-533A 1953 Part 1 Nov 16 2003. American Society of Hematology 45th
annual meeting (2003), San Diego, CA;
21. Cokic VP, Jain N, Schechter AN. Activation of human G protein-coupled receptor
signaling pathway targeted genes by hydroxyurea in erythroid progenitor cells. Blood
vol: 102 (11) Blood 102 (11):156B-157B 4336 Part 2 Nov 16 2003. American Society
of Hematology 45th annual meeting (2003), San Diego, CA;
22. Inoue A, Kuroyanagi Y, Terui K, Cokic VP, Schechter AN, Ausenda S, Cappellini
MD, Ikuta T. Intracellular signaling pathways that control fetal to beta-globin gene
switching. Blood 102 (11):46A-47A 151 Part 1 Nov 16 2003. American Society of
Hematology 45th annual meeting (2003), San Diego, CA;
23. Cokic VP, Milenkovic P, Schechter AN. Hydroxyurea induction of nitric oxide
production in human bone marrow endothelial cells. XII Hematološki dani SCG.
(2004) Niš.
24. Cokic VP, Economou AP, Wahl LM, Milenkovic P, Schechter AN. G protein-coupled
receptors in hydroxyurea activation of nitric oxide/cGMP pathways and gammaglobin induction. Experimental Hematology 33 (7):80-80 161 Suppl. 1 Jul 2005. 34th
Annual Scientific Meeting of the International Society for Experimental Hematology
(2005), University of Glasgow, Glasgow, Scotland, UK.
25. Cokic VP, Beleslin-Cokic BB, Noguchi CT, Schechter AN. Hydroxyurea induces
eNOS activity and protein levels in endothelial cells. Experimental Hematology 33
(7):87-88 190 Suppl. 1 Jul 2005. 34th Annual Scientific Meeting of the International
Society for Experimental Hematology (2005), Glasgow, Scotland, UK.
26. Cokic VP, Bhattacharya B, Puri RK, Schechter AN. Developmental and Differential
Changes of Gene Expression in Erythroid Progenitor Cells. Blood 106 (11):1015A1016A 3648 Part 1 Nov 16 2005. American Society of Hematology 47th annual
meeting (2005), Atlanta, Georgia;
27. Beleslin-Cokic B, Cokic VP, Gojkovic L, Noguchi C. Erythropoietin stimulation of
erythropoietin receptor in lung microvascular endothelial cells. 7th International
Luebeck Conference on the Pathophysiology and Pharmacology of Erythropoietin and
other Hemopoietic Growth Factors September 6-9, 2006. University of Luebeck,
Germany.
28. Beleslin-Cokic B, Cokic VP, Gojkovic L, Noguchi C. Effect of erythropoietin on
human isolated blood vessel and vascular smooth muscle cells. 7th International
Luebeck Conference on the Pathophysiology and Pharmacology of Erythropoietin and
other Hemopoietic Growth Factors September 6-9, 2006. University of Luebeck,
Germany.
29. Cokic VP, Bhattacharya B, Smith RD, Beleslin-Cokic BB, Noguchi CT, Puri RK,
Schechter AN. Gene expression profiling in fetal and adult definitive erythropoiesis.
Blood
Cells,
Molecules,
and
Diseases
38
(2),
2007:120-191.
15th Conference on Hemoglobin Switching, September 14 - 18, 2006. St. John’s
College, Oxford, United Kingdom.
30. Cokic VP, Beleslin-Cokic BB, Noguchi CT, Schechter AN. Hydroxyurea nitrosylates
and activates soluble guanylyl cyclase in human erythroid cells. Experimental
Hematology 35 (9):106 P193 Suppl. S, September 2007. 36th Annual Scientific
Meeting of the International Society for Experimental Hematology (2007), Hamburg,
Germany.
31. Beleslin-Cokic B, Cokic VP, Gojkovic L, Noguchi C. Erythropoietin signaling and
response in vascular smooth muscle cells. Blood 110 (11): 3724 Nov 16 2007.
American Society of Hematology 49th annual meeting (2007), Atlanta, Georgia;
32. Cokic VP, Beleslin-Cokic BB, Noguchi CT, Schechter AN. Globin genes induction by
nitric oxide of stromal cell origin. Blood 110 (11): 4102 Nov 16 2007. American
Society of Hematology 49th annual meeting (2007), Atlanta, Georgia;
33. Cokic VP, Beleslin-Cokic BB, Noguchi CT, Schechter AN. P96. Globin gene
stimulation by nitric oxide produced by the hematopoietic microenvironment. Nitric
Oxide 19, Supplement 1, Pages S1-S74 (2008), p.65-66.
34. Čokić VP, Han J, Mojsilović S, Beleslin-Čokić BB, Mirković K, Kraguljac-Kurtović
N, Damjanović S, Pavle Milenković P, Gotić M, Skoda RC, Raj PK, Noguchi CT,
Schechter AN. Gene expression profiling of CD34+ cells in myeloproliferative
disorders by cDNA microarray technology. Haematologica / The Hematology Journal
2009;June:94, Supplement 2, Page 352 (P0874).
35. Beleslin-Cokic BB, Cokic VP, Schechter AN, Noguchi CT. Erythropoietin and
hypoxia commonly increase erythropoietin receptor and low nitric oxide levels in lung
microvascular endothelial cells. 8th International Luebeck Conference on the
Pathophysiology and Pharmacology of Erythropoietin and other Hemopoietic Growth
Factors. July 30 - August 01, 2009. University of Luebeck, Germany.
36. Antic D, Cokic VP, Dencic Fekete M, Perunicic M, Mihaljevic B, Boskovic D.
Prognostic Value of Angiogenesis Assessment in Chronic Lymphocytic Leukemia:
More Data Needed. Blood 114 (22): 4396. Nov 20 2009. American Society of
Hematology 51th annual meeting (2009), New Orleans, Louisiana, US;
37. Antic D, Fekete MD, Cokic VP, Jovanovic MP, Dragovic T, Mihaljevic B. Prognostic
value of vascular endothelial growth factor (VEGF) serum level and
immunohistochemical expression in non-treated patient with chronic lymphocytic
leukemia. Thrombosis research 2010 125 (Suppl. 2):S189-S189. (April 2010)
38. A Krstic, J Kocic, S Mojsilovic, I Okic, V Ilic, V Cokic, JF Santibanez, G Jovcic, D
Bugarski. Erythropoietic effects of IL-17: involvement of MAPKs and GATA
transcription factors. Haematologica / The Hematology Journal 2010;June:95,
Supplement 2, Page 36 (P0092). 15th Congress of the European Hematology
Association, Barcelona, Spain. June 10-13, 2010.
39. V Cokic, S Mojsilovic, V Miloševic, N Kraguljac-Kurtovic, A Bogdanovic, G Jovcic,
P Milenkovic, M Gotic, C Noguchi, A Schechter. Gene expression profile of
circulating hematopoietic progenitor cells vs. granulocytes in chronic myeloid
leukemia. Haematologica / The Hematology Journal 2010;June:95, Supplement 2,
Page 334 (P0799). 15th Congress of the European Hematology Association,
Barcelona, Spain. June 10-13, 2010.
40. V Cokic, J Han, B Beleslin-Cokic, K Mirkovic, S Damjanovic, M Gotic, P Raj, C
Noguchi, A Schechter. Therapy related gene expression of hematopoietic progenitor
cells in chronic myeloproliferative neoplasms. Haematologica / The Hematology
Journal 2010;June:95, Supplement 2, Page 403 (P0973). 15th Congress of the
European Hematology Association, Barcelona, Spain. June 10-13, 2010.
41. D Antic, V Cokic, M Dencic Fekete, M Perunicic Jovanovic, V Milosevic, N
Kraguljac Kurtovic. Serum level of vascular endothelial growth factor (VEGF) as
prognostic parameter in untreated patients with B-cell chronic lymphocytic leukemia.
Haematologica / The Hematology Journal 2010;June:95, Supplement 2, Page 524
(P1288). 15th Congress of the European Hematology Association, Barcelona, Spain.
June 10-13, 2010.
ORAL PRESENTATIONS:
1. Cokic VP, Smith RD, Beleslin-Cokic BB, Gladwin MT, Schechter AN. Nitric
oxide donors and hydroxyurea induce fetal hemoglobin by a mechanism involving
cGMP. 30th Anniversary Combined Meeting of the National Sickle Cell Disease
Program and the Sickle Cell Disease Association of America, (2002) Washington
Hilton & Towers Hotel, Washington, DC.
2. Čokić VP, Milenkovic P, Schechter AN. Hydroxyurea and nitric oxide effects on
the proliferation of human erythroleukemic cells. 5th Congress of the Balkan
Union of Oncology. (2004), Belgrade, Serbia.
3. Čokić VP, Milenković P, Schechter AN. Nitric oxide influence on erythroleukemic
cell growth. Immunotherapy of cancers. (2005) Serbian academy of science and
art, Belgrade, Serbia.
4. Čokić VP, Milenković P, Schechter AN. Hydroxyurea stimulates eNOS - cGMP
Pathway in Endothelial Cells. The first congress of physiological sciences of
Serbia and Montenegro with international participation. Military Medical
Academy, (2005) Belgrade, Serbia.
5. Čokić VP. Gene expression in hematopoietic progenitor cells of patients with
myeloproliferative neoplasms. Ekspresija gena u progenitornim ćelijama
hematopoeze u mijeloproliferativnim bolestima. 45th Cancer days, (2008) Sava
Centre, Belgrade, Serbia.
6. Čokić VP. Gene Expression Profiling of Hematopoietic Progenitor Cells in
Myeloproliferative Disorders. 8th Balkan Meeting on Human Genetics. Hotel
Croatia, Cavtat, Croatia, May 14-17, 2009.